MOLLY JARRELS: Open Payments
NPI 1740949882 · HARRISONBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 44 payments from 12 companies in 2025. Trend: 2023 $154 · 2024 $88 · 2025 $1,613
Food & beverage: $1,180Education: $433
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $545 |
| ABBVIE INC. | 6 | $205 |
| Regeneron Healthcare Solutions, Inc. | 5 | $193 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $164 |
| UCB, Inc. | 6 | $146 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| GENZYME CORPORATION | 1 | $32 |
| Incyte Corporation | 1 | $24 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, VOQUEZNA, Sotyktu, ILUMYA, COSENTYX.
Industry payments across VA — which companies pay providers there.
